Skip to main content

Table 1 Clinicopathological data of the Ollier patients

From: Genome-wide analysis of Ollier disease: Is it all in the genes?

Patient ID Sample Tumor Grade Tumor location Gender Age Application
17 L1083 CS I metacarpal M 48 1,3
17 L2218 CS I phalanx M 49 1,3
20 L286* CS II femur F 23 1,3
21 L204* CS I femur M 26 1,3
21 L253* CS I tibia M 26 1,3
22 L206 EC phalanx F 26 1,2,3,4
22 L910 EC phalanx F 16 1,2,3,4
23 L813 CS II humerus M 68 1,3
25 L1251* EC phalanx M 15 1,2,3,4
25 L2220* EC metacarpal M 14 1,3,4
26 L1974 CS II scapula M 48 1,3
27 L1975* CS II femur M 31 1,3
28 L1976* CS II tibia M 41 1,3
29 L1977* CS I tibia M 41 1,3
29 L1978* EC foot M 38 1,3
30 L1980 CS II knee F 63 1,3
31 L810 CS III unknown M - 1,3
33 L1685 CS I pubic bone F 23 1,3
34 L1687 CS I phalanx M 18 1,3
34 L1686 EC phalanx M 18 1,2,3,4
35 L2386 CS I phalanx F 13 1,3
36 L2463* EC tibia F 12 1,3
38 L1629 EC unknown M 36 1,3
38 L1630 EC Iliac bone M 36 1,2,3,4
42 L2098 CS II humerus F 15 1,3
43 L2099 CS II humerus F 49 1,3
47 L2103a EC phalanx M 39 1,2,3,4
47 L2103b CS I phalanx M 39 1,3
48 L2104a CS III tibia M 35 1,3
48 L2104b EC femur M 35 1,3
50 L2221* CS I femur F 42 1,3
52 L1513* CS I femur F 23 1,3
54 L1490* EC phalanx F 12 1,3
61 L2205 EC ilium M 6 1,3
64 L1683 EC metacarpal F 29 1,2,3,4
68 L2280* CS I acromion F 24 1,3
69 L2513 CS I pelvis M 33 1,3
  1. * Normal DNA available enabling paired analysis. Application - 1: sample used for SNP array, 2: expression array, 3: MLPA and 4: qRT-PCR.